Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Biotin supplements may help hair regrowth in some alopecia areata patients.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

Taurine may help reduce hair loss by improving hair growth cycles.

A more sensitive assay was developed to detect enzyme activity converting arginine to citrulline in hair follicles.

AMT may be more effective than finasteride for hair growth in androgenetic alopecia.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

Non-immune factors play a significant role in alopecia areata.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Higher Alarin levels may predict androgenetic alopecia and metabolic syndrome.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Higher adrenaline and prolactin levels may indicate stress-related alopecia areata in adults.

Low levels of tenuazonic acid can severely damage vital organs.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

IMA and IMA/albumin levels don't predict alopecia areata severity.

ESR2 gene linked to female-pattern hair loss.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Gene variations may increase oxidative stress in male pattern baldness.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Biotin supplements may help hair regrowth in alopecia areata patients with low biotinidase activity.